Fresenius Kabi Makes Progress On Tocilizumab

Reports Positive Phase I Results For Actemra/Ro-Actemra Biosimilar

 
• By David Wallace
  
Tocilizumab injection Syringe
Fresenius Kabi’s MSB11456 tocilizumab candidate is moving ahead • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products